Trial

NCT04313972

IC PaIN Trial: Interstitial Cystitis Pain Improvement With Naltrexone
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Endeavor Health
Collaborators
Condition
Interstitial Cystitis
Intervention
low-dose naltrexone
Why stopped
There was a delay in recruitment initiation due to COVID-19 and internal logistical challenges. Following this delay, the principal investigator left the study site, and it was determined that the study should be terminated.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-03-07